M. Frier - Concepedia

Author

M. Frier

Queen's Medical Centre

Also Known As

M FRIER, M Frier, M. FRIER, M. Frier, MALCOLM FRIER, Malcolm Frier

109

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Queen's Medical Centre University of Nottingham University of Strathclyde Nottingham City Hospital Procter & Gamble (United States)

About

M. Frier is an author at Queen's Medical Centre specializing in medicine, biomedical engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	908
2	Engineering	5	5	689
3	Natural Sciences	3	3	101
4	Health Sciences	1	1	29
5	Anatomy	1	1	49

M. Frier

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the clearance characteristics of bioadhesive systems in humans R. J. Soane, M. Frier, Alan C. Perkins, International Journal of Pharmaceutics Tissue EngineeringEngineeringAdhesive MaterialClearance CharacteristicsBiomaterial Modeling	1999	358
Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape Lisbeth Ilium, S.S. Davis, C G Wilson, International Journal of Pharmaceutics NanoparticlesColloidal MaterialEngineeringColloidal ParticlesHematology	1982	251
LEAPT: Lectin-directed enzyme-activated prodrug therapy Mark Robinson, S.T. Charlton, Philippe Garnier, Proceedings of the National Academy of Sciences	2004	100
Ocular contact time of a carbomer gel (GelTears) in humans C G Wilson, Yinuo Zhu, M. Frier, British Journal of Ophthalmology	1998	75
Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract Howard N.E. Stevens, Clive Wilson, Peter G. Welling, International Journal of Pharmaceutics Human Gi TractGastrointestinal PharmacologyMedicineImmunologyGastroenterology	2002	68
Targeting Superficial Bladder Cancer by the Intravesical Administration of Copper-67–Labeled Anti-MUC1 Mucin Monoclonal Antibody C595 O. D. Hughes, M.C. Bishop, Alan C. Perkins, Journal of Clinical Oncology	2000	68
Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations Alan C. Perkins, Clive Wilson, M. Frier, International Journal of Pharmaceutics EsophagusSurgeryBiomedical EngineeringMedicineEsophageal Transit	1999	56
Mode of Action of the Antibacterial Compound Dequalinium Acetate W. B. Hugo, M. Frier Applied Microbiology Dequalinium AcetatePharmaceutical ScienceBioorganic ChemistryAntimicrobial ChemotherapyChemical Biology	1969	49
The effect of the nasal cycle on mucociliary clearance R. J. Soane, A. Simon Carney, Nicholas S. Jones, Clinical Otolaryngology AsthmaNose AlternateNasal CavityOtorhinolaryngologyLarynx	2001	49
Oesophageal transit, disintegration and gastric emptying of a film‐coated risedronate placebo tablet in gastro‐oesophageal reflux disease and normal control subjects Alan C. Perkins, Clive Wilson, M. Frier, Alimentary Pharmacology & Therapeutics	2001	33

Page 1